8-K - Boundless Bio, Inc. - 1.02 / 2.03
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-153076
Filing Date: 2026-04-13
Accepted: 2026-04-13 17:15:10
Documents: 9
Period of Report: 2026-04-13
Items: Item 1.02: Termination of a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Boundless Bio, Inc. (Filer) CIK : 0001782303 (see all company filings) EIN. : 830751369 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41989 | Film No.: 26858505 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | bold-20260413.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | bold-20260413.xsd | EX-101.SCH
12 | EXTRACTED XBRL INSTANCE DOCUMENT | bold-20260413_htm.xml | XML